• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

Incidence and Clinical Impact of Stroke Complicating Percutaneous Coronary Intervention: Results of the Euro Heart Survey Percutaneous Coronary Interventions Registry Cardiac Catheterization
Conclusions— Stroke as complication of PCI occurs rarely (0.4%) in clinical practice in Europe today. However, peri-interventional stroke is still associated with an exceedingly high in-hospital mortality rate. Most predictors for periprocedural stroke are not modifiable and cannot be diminished before PCI. Therefore, treatment of patients with stroke after PCI needs further research.
Source: Circulation: Cardiovascular Interventions - August 20, 2013 Category: Cardiology Authors: Werner, N., Bauer, T., Hochadel, M., Zahn, R., Weidinger, F., Marco, J., Hamm, C., Gitt, A. K., Zeymer, U. Tags: Acute Stroke Syndromes Cardiac Catheterization Source Type: research

Stroke After Primary Percutaneous Coronary Intervention in Patients With ST-Segment Elevation Myocardial Infarction: Timing, Characteristics, and Clinical Outcomes Coronary Artery Disease
Conclusions— Stroke is an infrequent complication in the setting of ST-segment elevation myocardial infarction treated with primary PCI but is associated with increased morbidity and mortality. Studies to determine mechanisms that may be responsible for strokes that occur >48 hours from primary PCI are warranted. Clinical Trial Registration— URL: http://www.clinicaltrials.gov. Unique identifier: NCT00091637.
Source: Circulation: Cardiovascular Interventions - April 16, 2013 Category: Cardiology Authors: Guptill, J. T., Mehta, R. H., Armstrong, P. W., Horton, J., Laskowitz, D., James, S., Granger, C. B., Lopes, R. D. Tags: Coronary Artery Disease Source Type: research

Effect of prompt revascularization on outcomes in diabetic patients with stable ischemic heart disease and previous myocardial infarction in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial
Conclusion: In diabetic patients with SIHD and previous MI, adding prompt revascularization to intensive medical therapy yielded no benefit compared with intensive medical therapy alone. These findings underscore the importance of intensive medical therapy in mitigating further ischemic events.
Source: Coronary Artery Disease - April 27, 2017 Category: Cardiology Tags: Original Research Source Type: research

The presence of angiographic collaterals in non‐ST elevation myocardial infarction is a predictor of long‐term clinical outcomes
Conclusions: In patients with NSTEMI the presence of angiographic coronary collaterals is a predictor of long‐term clinical outcomes primarily driven by increased rates of surgical revascularization. © 2013 Wiley Periodicals, Inc.
Source: Catheterization and Cardiovascular Interventions - May 22, 2013 Category: Cardiovascular & Thoracic Surgery Authors: Angela M. Kloepfer, Lewis C. Lipson, Ellen C. Keeley Tags: Original Studies Source Type: research

Utilization of triple antithrombotic therapy in patients with atrial fibrillation undergoing percutaneous coronary intervention
ConclusionsThe utilization of TAT following PCI among high-stroke risk AF patients steadily increased from 2011 to 2020, reaching 65.4% by the end of the study period. However, in 2020, a significant proportion of 29.4% of patients still received DAPT, indicating that many AF patients undergoing PCI did not receive adequate antithrombotic therapy.
Source: European Journal of Clinical Pharmacology - February 24, 2023 Category: Drugs & Pharmacology Source Type: research

Coronary artery bypass grafting vs percutaneous coronary intervention in a 'real-world' setting: a comparative effectiveness study based on propensity score-matched cohorts ADULT CARDIAC
CONCLUSIONS In the ‘real-world’ setting of this study, CABG was associated with significantly lower rates of death, MI and TVR in patients with LMCA or multivessel disease, so it remains the standard of care, particularly for patients with more extensive coronary disease and diabetes.
Source: European Journal of Cardio-Thoracic Surgery - June 13, 2013 Category: Cardiovascular & Thoracic Surgery Authors: Fortuna, D., Nicolini, F., Guastaroba, P., De Palma, R., Di Bartolomeo, S., Saia, F., Pacini, D., Grilli, R., on behalf of RERIC (Regional Registry of Cardiac Surgery), REAL (Regional Registry of Coronary Angioplasties) Investigators Tags: ADULT CARDIAC Source Type: research

Triple Therapy for Atrial Fibrillation and Percutaneous Coronary Intervention A Contemporary Review
Chronic oral anticoagulant therapy is recommended (class I) in patients with mechanical heart valves and in patients with atrial fibrillation with a CHA2DS2-VASc (Congestive heart failure, Hypertension, Age ≥75 years, Diabetes mellitus, prior Stroke or transient ischemic attack or thromboembolism, Vascular disease, Age 65 to 74 years, Sex category) score ≥1. When these patients undergo percutaneous coronary intervention with stenting, treatment with aspirin and a P2Y12 receptor inhibitor also becomes indicated. Before 2014, guidelines recommended the use of triple therapy (vitamin K antagonists, aspirin, and clopidog...
Source: Journal of the American College of Cardiology: Cardiovascular Interventions - September 15, 2014 Category: Cardiology Source Type: research

Abstract 166: Developing the Veterans Affairs Cardiac Risk Score Session Title: Poster Session I
Conclusion: We demonstrated that an EHR in a specific population could risk-stratify patients as well those from as organized cohort studies and greatly improve calibration. Further, our finding that the ASCVD score greatly underpredicted in our population, while previous work have reported the ASCVD over-predictind in other cohorts, suggests that rather than arguing about which risk tool is best, our patients may be better served by us focusing on calibrating CV risk tools for our specific patient population using their EHR data.
Source: Circulation: Cardiovascular Quality and Outcomes - April 29, 2015 Category: Cardiology Authors: Sussman, J. B., Wiitala, W., Hofer, T., Zawitowski, M., Vijan, S., Hayward, R. Tags: Session Title: Poster Session I Source Type: research

Use of TIMI Risk Index as a Simple and Valuable Prognostic Tool in Patients with ST-Segment Elevation Myocardial Infarction Who Underwent Primary Percutaneous Coronary Intervention
CONCLUSION: The results of this study indicated that Thrombolysis in Myocardial Infarction Risk Index value is an independent predictor of clinical outcomes such as death and heart failure but not subsequent myocardial infarction in ST-segment elevation myocardial infarction patients. The use of Thrombolysis in Myocardial Infarction Risk Index can be considered in ST-segment elevation myocardial infarction patients who underwent primary percutaneous coronary intervention as it is an easily applicable and important indicator of prognosis.PMID:35450843 | DOI:10.5152/tkda.2022.21143
Source: Turk Kardiyoloji Dernegi arsivi - April 22, 2022 Category: Cardiology Authors: İdris Buğra Çerik Ahmet Kaya Se çkin Dereli Fatih Akkaya Mustafa Yener çağ Osman Bekta ş Source Type: research

Pages: 1  2  3  4  5  6  7